Floatz logo

CIS-DIAMMINEDICHLOROPLATINUM II

Adult T-cell Leukemia-Lymphoma

Kyowa Kirin, Inc.Small moleculePhase 2Dormant
BB
67/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
52/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Adult T-cell Leukemia-Lymphoma cohort.

Asset / SponsorPhaseRating
MOGAMULIZUMAB
Memorial Sloan Kettering Cancer Center
Phase 2BB
Cytosin-Arabinosid
Fred Hutchinson Cancer Center
Phase 2BB
Eloxatin
Kyowa Kirin, Inc.
Phase 2B
RANIMUSTINE
Kyowa Kirin Co., Ltd.
Phase 2B
VINDESINE
The First Affiliated Hospital of Soochow University
Phase 2B

View all 10 →

Same molecule, other indications

CIS-DIAMMINEDICHLOROPLATINUM II is also rated in:

squamous cell lung carcinomaDormant
BBB
Indicative ·
78 / 100
View asset →
primary peritoneal carcinomaDormant
BBB
Indicative ·
77 / 100
View asset →
adenocarcinomaDormant
BBB
Indicative ·
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →